Congratulations to the following individuals for obtaining extramural funding from federal,
state, and/or independent sources between May 1 – July 31, 2020!

NOTE: If any information has been inadvertently omitted, please contact the editor (dflock@lsuhsc.edu)
and a correction will be printed in the next issue of The Pulse.

National Institutes of Health (R01):

  • Hari Koul, PhD (Department of Urology)
    • “Prostate Cancer Health Disparity: Role of PDEF”

Health and Human Services

  • Lee Michals, MD (Department of Psychiatry)
    • Addiction Medicine Fellowship

Foundations and National Associations:

  • Whitney Walkowski (Neuroscience Center of Excellence)
    • American Philosophical Society – Lewis and Clark Grant
    • “Relationship Between Color Signals and Color Sensitivity: A Comparative Approach”
  • Whitney Walkowski (Neuroscience Center of Excellence)
    • The Herpetologists’ League
    • “Endocrine Control of Retinal Sensitivity in Hyla Cinerea”

Pharmaceutical and Company Grants:

  • Murtuza Ali, MD (Department of Medicine, Section of Cardiology)
    • Analytics for Life
    • “Repository of Phase Signals for Pulmonary Hypertension Algorithm Development (PHDEV)”
  • Rebecca Shea Buckley, PhD (Department of Biochemistry & Molecular Biology)
    • Chosen Diagnostics
    • “SBIR Phase 1: Absolute Protein Quantitation in In Vitro Diagnostics for Gut Inflammation”
  • Paul LeLorier, MD (Department of Medicine)
    • Abbott Laboratories
    • Electrophysiology Fellowship Sponsorship
  • Paul LeLorier, MD (Department of Medicine)
    • Medtronic, Inc.
    • Fellowship
  • Frank Smart, MD (Department of Medicine)
    • Ionis Pharmaceuticals, Inc.
    • “A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Thansthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)”
  • Stephanie Taylor, MD (Department of Microbiology, Immunology and Parasitology)
    • Becton Dickinson Group
    • “Clinical Evaluation of the BD MAX™ STI Plus Assay, when performed on the BD MAX System”
  • Stephanie Taylor, MD (Department of Microbiology, Immunology and Parasitology)
    • Leidos Biomedical Research, Inc.
    • “A Multicenter Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

LSU LIFT Grants:

  • Suresh Alahari, PhD (Department of Biochemistry & Molecular Biology)
    • “Moxonidine is a Potential New Drug for Triple Negative Breast Cancers”
  • Rinku Majumder, PhD (Department of Biochemistry and Molecular Biology)
    • “Development of Peptide Mimic of Protein S, a Physiological Anticoagulant for Antithrombotic Therapy”